← Back to Clinical Trials
Recruiting NCT05926622
Clinical and Radiological Outcomes of Medacta Shoulder System FR
Trial Parameters
Condition Primary Osteoarthritis
Sponsor Medacta International SA
Study Type OBSERVATIONAL
Phase N/A
Enrollment 200
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2022-03-15
Completion 2032-03
Brief Summary
This is a post-marketing surveillance on Medacta Shoulder System
Eligibility Criteria
Inclusion Criteria: * Patients older than 18 years * Patient with one of the following diagnosis: Primary osteoarthritis Secondary osteoarthritis Cuff tear arthropathy; insufficient rotator cuff Acute fracture (\<21d) Rheumatoid or inflammatory arthritis Avascular necrosis Other posttraumatic condition Revision of shoulder arthroplasty Exclusion Criteria: * Patients with malignant diseases (at the time of surgery) * Patients with proven or suspect infections (at the time of surgery) * Patients with functional deficits other than dysfunction of the shoulder (at the time of surgery) * Patients with known incompatibility or allergy to products materials (at the time of surgery)